Collaborate only after consent.

CWC — Collaborate With Consent: get it in writing first.

Picture this rule in practice: Eligible patients or their representatives must give written consent before New York collaborative drug therapy management is used.

A pharmacist has a valid collaborative drug therapy management protocol for a patient. Which additional step is required before the pharmacist uses CDTM for that patient?

A. Obtain the patient's or authorized representative's written consent

B. Ask the patient to waive access to the medical record

C. Submit a new pharmacy registration

D. Replace the physician's drug without protocol authorization

Collaborate only after consent.

CWC — Collaborate With Consent: get it in writing first.

Picture this rule in practice: Eligible patients or their representatives must give written consent before New York collaborative drug therapy management is used.

A pharmacist has a valid collaborative drug therapy management protocol for a patient. Which additional step is required before the pharmacist uses CDTM for that patient?

A. Obtain the patient's or authorized representative's written consent

B. Ask the patient to waive access to the medical record

C. Submit a new pharmacy registration

D. Replace the physician's drug without protocol authorization

Collaborate only after consent.

CWC — Collaborate With Consent: get it in writing first.

Picture this rule in practice: Eligible patients or their representatives must give written consent before New York collaborative drug therapy management is used.

A pharmacist has a valid collaborative drug therapy management protocol for a patient. Which additional step is required before the pharmacist uses CDTM for that patient?

A. Obtain the patient's or authorized representative's written consent

B. Ask the patient to waive access to the medical record

C. Submit a new pharmacy registration

D. Replace the physician's drug without protocol authorization

Collaborate only after consent.

CWC — Collaborate With Consent: get it in writing first.

Picture this rule in practice: Eligible patients or their representatives must give written consent before New York collaborative drug therapy management is used.

A pharmacist has a valid collaborative drug therapy management protocol for a patient. Which additional step is required before the pharmacist uses CDTM for that patient?

A. Obtain the patient's or authorized representative's written consent

B. Ask the patient to waive access to the medical record

C. Submit a new pharmacy registration

D. Replace the physician's drug without protocol authorization